Literature DB >> 14605247

Angiotensin II receptor blockade inhibits pneumocyte apoptosis in experimental meconium aspiration.

Heikki Lukkarinen1, Jukka Laine, Jani Lehtonen, Alexander Zagariya, Dharmapuri Vidyasagar, Heikki Aho, Peka Kääpä.   

Abstract

Lung tissue inflammation and apoptosis are implicated in the pathogenesis of meconium aspiration-induced lung injury in the newborn, but the mechanisms of these reactions are still poorly known. We investigated the time-dependent leukocyte influx and appearance of apoptosis, as well as the contribution of angiotensin (ANG) II receptor action on these processes in the meconium-induced lung injury. Experimental meconium aspiration was induced by intratracheal instillation of human meconium in 18 rats, and eight rats were further pretreated with an unspecific ANG II receptor inhibitor saralasin. Rats were ventilated with 60% oxygen for 1, 3, or 5 h, and the lungs were then studied histologically for tissue injury and with DNA nick-end labeling and electron microscopy for apoptotic cell death. Lung tissue myeloperoxidase activity and expression of angiotensinogen mRNA and endothelial monocyte-activating polypeptide (EMAP) II protein were also analyzed. The meconium-instilled lungs showed increasing neutrophil migration and histologic injury after the first hour, whereas the number of epithelial apoptotic cells was elevated from the control level throughout the study. Myeloperoxidase activity was high, and the angiotensinogen mRNA and EMAP II protein was up-regulated at 5 h after the meconium insult. Pretreatment with saralasin significantly prevented the increase in lung tissue myeloperoxidase activity, EMAP II, and lung epithelial apoptosis. The results suggest that pulmonary meconium insult rapidly results in epithelial apoptosis, before significant neutrophil sequestration into the lungs. Apoptotic cell death is further connected with ANG II receptor action in the meconium-contaminated lung tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605247     DOI: 10.1203/01.PDR.0000100901.88697.66

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.

Authors:  Jana Kopincova; Andrea Calkovska
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

2.  Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

3.  Protection of Meconium-Induced Lung Epithelial Injury by Protease Inhibitors.

Authors:  C Ota; I Gopallawa; V Ivanov; I H Gewolb; B D Uhal
Journal:  J Lung Pulm Respir Res       Date:  2017-11-20

4.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

5.  ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.

Authors:  Takafumi Minato; Tomokazu Yamaguchi; Midori Hoshizaki; Satoru Nirasawa; Jianbo An; Saori Takahashi; Josef M Penninger; Yumiko Imai; Keiji Kuba
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

Review 6.  The renin-angiotensin system in acute respiratory distress syndrome.

Authors:  Yumiko Imai; Keiji Kuba; Josef M Penninger
Journal:  Drug Discov Today Dis Mech       Date:  2006-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.